Operating room to bench for gastric cancer

Pathobiology

Volumn 78, Issue 6, 2011, Pages 320-327

  Yang, Han Kwang ^a  

^a Seoul National University Cancer Hospital   (South Korea)

Author keywords

Familial gastric cancer; Gastrectomy; Genome wide analysis; Hydrogels

Indexed keywords

GASTRIN;

ARTICLE; CANCER INCIDENCE; GASTRECTOMY; GENETIC ASSOCIATION; HUMAN; HYDROGEL; KOREA; OPERATING ROOM; PRIORITY JOURNAL; SEX DIFFERENCE; STOMACH CANCER; STOMACH CARCINOGENESIS;

FEMALE; GASTRECTOMY; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; PHENOTYPE; STOMACH NEOPLASMS; TISSUE BANKS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 82055185755     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000331225     Document Type: Article

References (77)

1. Jung KW, Park S, Kong HJ, Won YJ, Boo YK, Shin HR, Park EC, Lee JS: Cancer statistics in Korea: Incidence, mortality and survival in 2006-2007. J Korean Med Sci 2010; 25: 1113-1121.
2. Yoon SS, Yang HK: Lymphadenectomy for gastric adenocarcinoma: Should west meet east? Oncologist 2009; 14: 871-882.
3. Iriyama K, Miki C, Kitagawa T: Influence of tumour penetration on period of death after gastric cancer surgery. Br J Surg 1997; 84: 866-867. (Pubitemid 27235283)
4. Noguchi Y: Blood vessel invasion in gastric carcinoma. Surgery 1990; 107: 140-148. (Pubitemid 20057274)
5. Ikeguchi M, Katano K, Oka A, Tsujitani S, Maeta M, Kaibara N: Relationship between hematogenic metastasis of gastric cancer and the maximum extent of venous invasion by cancer cells in the gastric wall. Hepatogastroenterology 1995; 42: 660-665.
6. Schwarz RE, Zagala-Nevarez K: Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 2002; 9: 394-400. (Pubitemid 34496728)
7. Roviello F, Marrelli D, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, De Stefano A, Italian Research Group for Gastric Cancer: Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003; 90: 1113-1119. (Pubitemid 37152170)
8. Lee HJ, Kim YH, Kim WH, Lee KU, Choe KJ, Kim JP, Yang HK: Clinicopathological analysis for recurrence of early gastric cancer. Jpn J Clin Oncol 2003; 33: 209-214. (Pubitemid 43115260)
9. Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, Sugimachi K: Recurrence in early gastric cancer. Surgery 1990; 107: 489-495. (Pubitemid 20156649)
10. Han TS, Kong SH, Lee HJ, Ahn HS, Hur K, Yu J, Kim WH, Yang HK: Dissemination of free cancer cells from the gastric lumen and from perigastric lymphovascular pedicles during radical gastric cancer surgery. Ann Surg Oncol 2011, DOI: 10.1245/s10434-011-1620-1628.
11. Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, Ogawa M: Mechanisms of peritoneal metastasis after operation for non-serosa-invasive gastric carcinoma: An ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for peritoneal metastasis. Clin Cancer Res 2003; 9: 678-685. (Pubitemid 36182600)
12. Shimada S, Tanaka E, Marutsuka T, Honmyo U, Tokunaga H, Yagi Y, Aoki N, Ogawa M: Extensive intraoperative peritoneal lavage and chemotherapy for gastric cancer patients with peritoneal free cancer cells. Gastric Cancer 2002; 5: 168-172. (Pubitemid 35238897)
13. Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, Yonemura Y, Baba H: Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg 2009; 250: 242-246.
14. Guo YS, Townsend CM Jr: Roles of gastrointestinal hormones in pancreatic cancer. J Hepatobiliary Pancreat Surg 2000; 7: 276-285.
15. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Hakanson R: Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391-399. (Pubitemid 16136682)
16. Pisegna JR, Norton JA, Slimak GG, Metz DC, Maton PN, Gardner JD, Jensen RT: Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome. Gastroenterology 1992; 102: 767-778.
17. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P: Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 1995; 19(suppl 1):S8-S19.
18. Nakajima T, Konda Y, Izumi Y, Kanai M, Hayashi N, Chiba T, Takeuchi T: Gastrin stimulates the growth of gastric pit cell precursors by inducing its own receptors. Am J Physiol Gastrointest Liver Physiol 2002; 282:G359-G366. (Pubitemid 34651693)
19. Smith JP, Liu G, Soundararajan V, McLaughlin PJ, Zagon IS: Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 1994; 266:R277-R283.
20. Watson S, Durrant L, Morris D: Gastrin: Growth enhancing effects on human gastric and colonic tumour cells. Br J Cancer 1989; 59: 554-558. (Pubitemid 19111745)
21. Weinstock J, Baldwin GS: Binding of gastrin( 17) to human gastric carcinoma cell lines. Cancer Res 1988; 48: 932-937. (Pubitemid 18061889)
22. Thorburn CM, Friedman GD, Dickinson CJ, Vogelman JH, Orentreich N, Parsonnet J: Gastrin and colorectal cancer: A prospective study. Gastroenterology 1998; 115: 275-280. (Pubitemid 28363419)
23. Hur K, Kwak MK, Lee HJ, Park DJ, Lee HK, Lee HS, Kim WH, Michaeli D, Yang HK: Expression of gastrin and its receptor in human gastric cancer tissues. J Cancer Res Clin Oncol 2006; 132: 85-91. (Pubitemid 41752049)
24. Lee HK, Lee HJ, Hur K, Lee HS, Kim WH, Michaeli D, Choe KJ, Yang HK: Growth effect of gastrin on gastric cancer and its clinical implications for gastric cancer surgery. Oncol Rep 2005; 14: 383-388.
25. Ramanan RMK, Chellamuthu P, Tang L, Nguyen KT: Development of a temperaturesensitive composite hydrogel for drug delivery applications. Biotechnol Prog 2006; 22: 118-125. (Pubitemid 43221536)
26. Couffin-Hoarau AC, Leroux JC: Report on the use of poly(organo- phosphazenes) for the design of stimuli-responsive vesicles. Biomacromolecules 2004; 5: 2082-2087.
27. Ankareddi I, Brazel CS: Synthesis and characterization of grafted thermosensitive hydrogels for heating activated controlled release. Int J Pharm 2007; 336: 241-247. (Pubitemid 46670647)
28. Rathi R, Zentner GM, Jeong B: Biode gradable low molecular weight triblock poly(lactideco-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties. US Patent, 2000, No. 6(117)949.
29. Rathi R, Zentner GM: Biodegradable low molecular weight triblock poly(lactide-coglycolide) polyethylene glycol copolymers having reverse thermal gelation properties. US Patent, 1999, No. 6(004)573.
30. Cha Y, Choi YK, Bae YH: Thermosensitive biodegradable polymers based on poly(etherester) block copolymers. US Patent, 1997, No. 5(702)717.
31. Jeong B, Bae YH, Lee DS, Kim SW: Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997; 388: 860-862. (Pubitemid 27377054)
32. Zentner GM: Biodegradable, thermally reversible gels for drug delivery. The 9th International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, 1999.
33. Zhang J, Misra RD: Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater 2007; 3: 838-850. (Pubitemid 47382675)
34. Rapoport N: Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog Polym Sci 2007; 32: 962-990. (Pubitemid 47198285)
35. Choi SW, Kim JH: Design of surface-modified poly( D , L -lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Release 2007; 122: 24-30.
36. Bilensoy E, Gürkaynak O, Dogan AL, Hincal AA: Safety and efficacy of amphiphilic β -cyclodextrin nanoparticles for paclitaxel delivery. Int J Pharm 2008; 347: 163-170. (Pubitemid 350180328)
37. Pison U, Welte T, Giersig M, Groneberg DA: Nanomedicine for respiratory diseases. Eur J Pharmacol 2006; 533: 341-350. (Pubitemid 43340025)
38. John AE, Lukacs NW, Berlin AA, Palecanda A, Bargatze RF, Stoolman LM, Nagy JO: Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease. FASEB J 2003; 17: 2296-2298. (Pubitemid 39561471)
39. Kwak MK, Hur K, Yu JE, Han TS, Yanagihara K, Kim WH, Lee SM, Song SC, Yang HK: Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent. Invest New Drugs 2010; 28: 284-290.
40. Yu J, Lee HJ, Hur K, Kwak MK, Han TS, Kim WH, Song SC, Yanagihara K, Yang HK: The antitumor effect of a thermosensitive polymeric hydrogel containing paclitaxel in a peritoneal carcinomatosis model. Invest New Drugs 2010, DOI: 10.1007/s10637-010-9499-y.
41. Kim IJ, Kang HC, Shin Y, Park HW, Jang SG, Han SY, Lim SK, Lee MR, Chang HJ, Ku JL, Yang HK, Park JG: A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome. J Hum Genet 2004; 49: 591-595. (Pubitemid 40392420)
42. Kim IJ, Park JH, Kang HC, Shin Y, Lim SB, Ku JL, Yang HK, Lee KU, Park JG: A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet 2003; 40:e97.
43. Humar B, Toro T, Graziano F, Müller H, Dobbie Z, Kwang-Yang H, Eng C, Hampel H, Gilbert D, Winship I, Parry S, Ward R, Findlay M, Christian A, Tucker M, Tucker K, Merriman T, Guilford P: Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002; 19: 518-525. (Pubitemid 34461625)
44. Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, Yang HK, Kim WH, Goldenring JR: Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 2010; 139: 213-225.
45. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK, Kim VN: Functional links between clustered microRNAs: Suppression of cellcycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-1681.
46. Mori M, Mimori K, Yoshikawa Y, Shibuta K, Utsunomiya T, Sadanaga N, Tanaka F, Matsuyama A, Inoue H, Sugimachi K: Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002; 131:S39-S47. (Pubitemid 34118615)
47. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ: High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Ann Surg Oncol 2010; 17: 89-97.
48. Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E, Corsi C, Coggi G, Di Fiore PP, Bosari S: Gene expression analysis of early and advanced gastric cancers. Oncogene 2007; 26: 4284-4294. (Pubitemid 46975798)
49. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y: Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res 2002; 62: 7012-7017. (Pubitemid 35424095)
50. Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, Satoh S, Yamaguchi T, Imamura H, Inoue M, Shiozaki H, Nakamura Y: Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004; 23: 6830-6844. (Pubitemid 39280016)
51. Shah MA, Khanin R, Tang L, Janjigian YY, Klimstra DS, Gerdes H, Kelsen DP: Molecular classification of gastric cancer: A new paradigm. Clin Cancer Res 2011; 17: 2693-2701.
52. Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, Yoo BC, Kim HK, Park JG: Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays. Clin Cancer Res 2004; 10: 272-284. (Pubitemid 38114190)
53. Kim HK, Choi IJ, Kim HS, Kim JH, Kim E, Park IS, Chun JH, Kim IH, Kim IJ, Kang HC, Park JH, Bae JM, Lee JS, Park JG: NA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochem Biophys Res Commun 2004; 316: 781-789. (Pubitemid 38372162)
54. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, Tanigawa M, Takeuchi I, Matsuura K, Hijiya N, Nakada C, Kishida T, Kawahara K, Ito H, Murakami K, Fujioka T, Seto M, Moriyama M: Genome wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 2008; 216: 471-482.
55. Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, Kiviluoto T, Karjalainen-Lindsberg ML, Hollmén J, Knuutila S, Puolakkainen P, Monni O: Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 2008; 15: 817-825. (Pubitemid 352032407)
56. Junnila S, Kokkola A, Karjalainen-Lindsberg ML, Puolakkainen P, Monni O: Genome-wide gene copy number and expression analysis of primary gastric tumors and gastric cancer cell lines. BMC Cancer 2010; 10: 73.
57. Weiss MM, Kuipers EJ, Postma C, Snijders AM, Siccama I, Pinkel D, Westerga J, Meuwissen SG, Albertson DG, Meijer GA: Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003; 22: 1872-1879. (Pubitemid 36513146)
58. Tao J, Deng NT, Ramnarayanan K, Huang B, Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J, Lee M, Zhang S, Rha SY, Chung HC, Smoot DT, Ashktorab H, Kon OL, Cacheux V, Yap C, Palanisamy N, Tan P: CD44-SLC1A2 gene fusions in gastric cancer. Sci Transl Med 2011; 3: 77ra30.
59. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW: Serial analysis of gene expression. Science 1995; 270: 484-487.
60. Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H: Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004; 95: 385-392. (Pubitemid 38832680)
61. Oue N, Hamai Y, Mitani Y, Matsumura S, Oshimo Y, Aung PP, Kuraoka K, Nakayama H, Yasui W: Gene expression profile of gastric carcinoma. Cancer Res 2004; 64: 2397.
62. Oue N, Aung PP, Mitani Y, Kuniyasu H, Nakayama H, Yasui W: Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 2005; 69: 17-22. (Pubitemid 41433537)
63. Risch N, Merikangas K: The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517. (Pubitemid 26301653)
64. Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005; 6: 95-108. (Pubitemid 40179532)
65. Kruglyak L, Nickerson DA: Variation is the spice of life. Nat Genet 2000; 27: 234-236. (Pubitemid 32201838)
66. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, Sherry S, Mullikin JC, Mortimore BJ, Willey DL, Hunt SE, Cole CG, Coggill PC, Rice CM, Ning Z, Rogers J, Bentley DR, Kwok PY, Mardis ER, Yeh RT, Schultz B, Cook L, Davenport R, Dante M, Fulton L, Hillier L, Waterston RH, McPherson JD, Gilman B, Schaffner S, Van Etten WJ, Reich D, Higgins J, Daly MJ, Blumenstiel B, Baldwin J, Stange-Thomann N, Zody MC, Linton L, Lander ES, Altshuler D, International SNP Map Working Group: A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-933. (Pubitemid 32165347)
67. The International HapMap Consortium: The International HapMap Project. Nature 2003; 426: 789-796.
68. Yoshida T, Ono H, Kuchiba A, Saeki N, Sakamoto H: Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example. Cancer Sci 2010; 101: 1582-1589.
69. Yoshida T, Yoshimura K: Outline of disease gene hunting approaches in the Millennium Genome Project of Japan. Proc Jpn Acad 2003; 79: 34-50.
70. Study Group of Millennium Genome Project for Cancer, Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura H, Tanioka F, Kato S, Matsukura N, Matsuda N, Nakamura T, Hyodo I, Nishina T, Yasui W, Hirose H, Hayashi M, Toshiro E, Ohnami S, Sekine A, Sato Y, Totsuka H, Ando M, Takemura R, Takahashi Y, Ohdaira M, Aoki K, Honmyo I, Chiku S, Aoyagi K, Sasaki H, Ohnami S, Yanagihara K, Yoon KA, Kook MC, Lee YS, Park SR, Kim CG, Choi IJ, Yoshida T, Nakamura Y, Hirohashi S: Genetic variation in PSCA is associated with susceptibility to diffusetype gastric cancer. Nat Genet 2008; 40: 730-740.
71. Matsuo K, Tajima K, Suzuki T, Kawase T, Watanabe M, Shitara K, Misawa K, Ito S, Sawaki A, Muro K, Nakamura T, Yamao K, Yamamura Y, Hamajima N, Hiraki A, Tanaka H: Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese. Int J Cancer 2009; 125: 1961-1964.
72. Lu Y, Chen J, Ding Y, Jin G, Wu J, Huang H, Deng B, Hua Z, Zhou Y, Shu Y, Liu P, Hu Z, Shen J, Xu Y, Shen H: Genetic variation of PSCA gene is associated with the risk of both diffuse and intestinal type gastric cancer in a Chinese population. Int J Cancer 2010; 127: 2183-2189.
73. Wu C, Wang G, Yang M, Huang L, Yu D, Tan W, Lin D: Two genetic variants in prostate stem cell antigen and gastric cancer susceptibility in a Chinese population. Mol Carcinog 2009; 48: 1131-1138.
74. Lochhead P, Frank B, Hold GL, Rabkin CS, Ng MT, Vaughan TL, Risch HA, Gammon MD, Lissowska J, Weck MN, Raum E, Müller H, Illig T, Klopp N, Dawson A, McColl KE, Brenner H, Chow WH, El-Omar EM: Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology 2011; 140: 435-441.
75. Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H, Meidtner K, Trichopoulos A, Tsiotas K, Zylis D, Vineis P, Panico S, Palli D, Krogh V, Tumino R, Lund E, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Quirós JR, Sánchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Hallmans G, Stenling R, Manjer J, Allen NE, Travis RC, Khaw KT, Jenab M, Offerhaus GJ, Riboli E, González CA: Prostate stem cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: Results from the EPIC EURGAST study. Int J Cancer 2011, DOI: 10.1002/ijc.26243.
76. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, Overvad K, Tjønneland A, Clavel-Chapelon F, Thiébaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, González CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R: European Prospective Investigation into Cancer and Nutrition (EPIC): Study populations and data collection. Public Health Nutr 2002; 5: 1113-1124. (Pubitemid 36313608)
77. Wang Z, Gerstein M, Snyder M: RNA-Seq: A revolutionary tool for transcriptomics. Nat Rev Genet 2009; 10: 57-63.